Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Optimizing Culture Medium Composition to Improve Oligodendrocyte Progenitor Cell Yields In Vitro from Subventricular Zone-Derived Neural Progenitor Cell Neurospheres.
Refining a Web-based goal assessment interview: item reduction based on reliability and predictive validity.
Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy.
Immunosenescence of microglia and macrophages: impact on the ageing central nervous system.
Nutrients, Microglia Aging, and Brain Aging.
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
Complement in neurobiology.
The many faces of impaired bladder emptying.
Molecular analysis of polimorphisms in HLA-CLASS II DRB1* and IL7Rα possibly associated with multiple sclerosis susceptibility in a population sample of Rio de Janeiro.
New data confirm high efficacy of Gilenya® in achieving 'no evidence of disease activity (NEDA)' based on four key measures of MS
Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters.
Alemtuzumab: evidence for its potential in relapsing-remitting multiple sclerosis.
Systematic review of pharmacologic therapies for neuropathic pain associated with stroke, HIV, trauma, and multiple sclerosis.
Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range.
Cell type- and brain region-resolved mouse brain proteome.
Time perception and illness acceptance among remitting-relapsing multiple sclerosis patients under treatment.
The role of melatonin in the pathogenesis of multiple sclerosis: a case-control study.
Features of Human CD3+CD20+ T Cells.
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
Diffusion tensor imaging of the trigeminal nerve in patients with trigeminal neuralgia due to multiple sclerosis.
Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.
Antibody Recognition In Multiple Sclerosis And Rett Syndrome Using A Collection Of Linear And Cyclic N-glucosylated antigenic probes.
Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis.
Promoting Physical Activity through a Manual Wheelchair Propulsion Intervention in Persons with Multiple Sclerosis.
Hyperperfusion of Multiple Sclerosis Plaques Characterized by 3D FSE Arterial Spin Labelling.
Pages
« first
‹ previous
…
612
613
614
615
616
617
618
619
620
…
next ›
last »